Stay updated on IPF/ILD-PRO Clinical Trial of Novel Therapy
Sign up to get notified when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.

Latest updates to the IPF/ILD-PRO Clinical Trial of Novel Therapy page
- Check5 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a consolidated Locations section listing state recruitment sites and updated the study revision to v3.3.3; removed the previous per-state location blocks and the HHS Vulnerability Disclosure link.SummaryDifference2%

- Check55 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study. Updated the revision label from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the notice about a lapse in government funding and the accompanying operating-status links (cc.nih.gov and opm.gov) from the page.SummaryDifference0.2%

- Check77 days agoChange DetectedThe screenshots show routine updates such as a refreshed 'Last Update Posted' timestamp and minor layout tweaks. Core study details, eligibility criteria, and enrollment information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedNew publication added to the Publications section: 'Mass spectrometry-based peripheral blood proteomics for biomarker discovery in idiopathic pulmonary fibrosis' (Respir Res. 2025 Oct 22;26(1):294). This minor update does not affect study details, eligibility, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to IPF/ILD-PRO Clinical Trial of Novel Therapy
Enter your email address, and we'll notify you when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.